Join Richmond Pharmacology at this year's 10th Annual Congress of the European Association for Clinical Pharmacology

Posted:
16
May 2011

Join Richmond Pharmacology at this year s 10th Annual Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), taking place on June 26-29 in Budapest, Hungary.The Congress will focus on key research and therapeutic areas, related challenges and latest achievements with the help of distinguished invited speakers, opinion leaders, experts and the upcoming future generation of clinical pharmacologists.We invite all attendees to join Richmond Pharmacology s Medical Director and Co-Founder Dr Ulrike Lorch at her presentation titled  frThe Use of Adaptive Study Design in Early Phase Clinical Research  scheduled for Day one, Session one at 10am.  For the full Scientific Programme of EACPT Congress please click here.In the last several years the interest in Adgaptive Study Design is evident from the growing amount of clinical research employing this model in the mid to later stages of medicines development.  Dr Lorch s presentation will describe where this design is of benefit to the conduct of First into Human and Early Phase Combination Studies and compare adaptive and conventional study design.  Little has been published on the practical application and merits of adaptive study design in Early Phase Clinical Research, so this presentation offers attendees a chance to learn more about the subject.If you would like to meet with Dr Ulrike Lorch, Richmond Pharmacology s CEO Dr Jorg Taubel.In the last several years the interest in Adaptive Study Design is evident from the growing amount of clinical research employing this model in the mid to later stages of medicines development.  Dr Lorchinfo@richmondpharmacology.com in advance to arrange a face-to-face meeting and discuss how Richmond Pharmacology can assist you with your current challenges.We hope to see you in Budapest to learn more about Richmond Pharmacology and enjoy one of Europe�s most lively cultural destinations.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more